BUHALY STEVEN J 4
4 · BioSig Technologies, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
BUHALY STEVEN J
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-16+250,000→ 250,000 totalExercise: $1.25Exp: 2033-02-15→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.